National Investment Services Inc. WI Has $1.64 Million Position in Allergan PLC. (AGN)

National Investment Services Inc. WI lessened its stake in shares of Allergan PLC. (NYSE:AGN) by 7.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,737 shares of the company’s stock after selling 509 shares during the period. National Investment Services Inc. WI’s holdings in Allergan PLC. were worth $1,638,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AGN. Jacobi Capital Management LLC raised its holdings in Allergan PLC. by 4.9% during the first quarter. Jacobi Capital Management LLC now owns 472 shares of the company’s stock worth $112,000 after acquiring an additional 22 shares in the last quarter. JNBA Financial Advisors raised its holdings in Allergan PLC. by 2.5% during the first quarter. JNBA Financial Advisors now owns 487 shares of the company’s stock worth $116,000 after acquiring an additional 12 shares in the last quarter. Webster Bank N. A. raised its holdings in Allergan PLC. by 31.0% during the first quarter. Webster Bank N. A. now owns 520 shares of the company’s stock worth $124,000 after acquiring an additional 123 shares in the last quarter. Pacific Center for Financial Services raised its holdings in Allergan PLC. by 805.1% during the first quarter. Pacific Center for Financial Services now owns 534 shares of the company’s stock worth $128,000 after acquiring an additional 475 shares in the last quarter. Finally, Ropes Wealth Advisors LLC raised its holdings in Allergan PLC. by 31.0% during the first quarter. Ropes Wealth Advisors LLC now owns 575 shares of the company’s stock worth $137,000 after acquiring an additional 136 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2017/09/16/national-investment-services-inc-wi-has-1-64-million-position-in-allergan-plc-agn.html.

Allergan PLC. (NYSE:AGN) opened at 220.29 on Friday. Allergan PLC. has a 52-week low of $184.50 and a 52-week high of $256.80. The stock has a 50 day moving average price of $231.75 and a 200 day moving average price of $236.59. The firm has a market cap of $73.64 billion, a P/E ratio of 6.71 and a beta of 1.18.

Allergan PLC. (NYSE:AGN) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $4.02 EPS for the quarter, topping analysts’ consensus estimates of $3.95 by $0.07. The company had revenue of $4.01 billion for the quarter, compared to analysts’ expectations of $3.95 billion. Allergan PLC. had a net margin of 79.17% and a return on equity of 7.37%. Allergan PLC.’s revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.35 EPS. Equities analysts predict that Allergan PLC. will post $16.25 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Friday, August 18th were issued a $0.70 dividend. The ex-dividend date was Wednesday, August 16th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.27%. Allergan PLC.’s dividend payout ratio (DPR) is presently 9.95%.

Several analysts recently issued reports on the company. Deutsche Bank AG reiterated a “buy” rating and set a $262.00 target price on shares of Allergan PLC. in a report on Tuesday. Wells Fargo & Company reiterated an “outperform” rating on shares of Allergan PLC. in a report on Monday, September 11th. Royal Bank Of Canada reiterated a “buy” rating and set a $285.00 target price on shares of Allergan PLC. in a report on Wednesday, September 6th. Cantor Fitzgerald reiterated a “hold” rating on shares of Allergan PLC. in a report on Tuesday, August 29th. Finally, Cowen and Company reiterated an “outperform” rating and set a $400.00 target price on shares of Allergan PLC. in a report on Tuesday, August 29th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $274.69.

Allergan PLC. Profile

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

Want to see what other hedge funds are holding AGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allergan PLC. (NYSE:AGN).

Institutional Ownership by Quarter for Allergan PLC. (NYSE:AGN)

Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply